Journal
TRENDS IN BIOTECHNOLOGY
Volume 34, Issue 8, Pages 618-626Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2016.05.004
Keywords
-
Categories
Funding
- Marie Curie International Outgoing Fellowship [626386]
Ask authors/readers for more resources
The promise of (nano)biomaterials for the treatment of cancer can only be realized following a comprehensive scrutiny of the tumor microenvironment. The generic use of 'inert' vehicles that deliver a specific cargo to treat a range of cancer types and disease states obeys the 'one material fits all' rule. However, this approach leads to suboptimal and unpredictable clinical outcomes. The key factors constructing the tumor milieu should guide the design of disease responsive materials. Given the growing availability of nanomaterials for cancer therapy, a material that responds to each patient's needs and, hence, reacts in a graded manner based on disease cues, would pave the way to precision materials for cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available